Recombinant Human Tissue Kallikrein-1 for Treating Acute Ischemic Stroke and Preventing Recurrence.

Kasner SE, Bath PM, Hill MD, Volpi JJ, Giuffre M, Masuoka L, Wambeke D, Madeddu PR

Open source

DOI
10.1161/strokeaha.124.048858
Published
2025 Mar
Container
Stroke
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1161/strokeaha.124.048858,
  title = {Recombinant Human Tissue Kallikrein-1 for Treating Acute Ischemic Stroke and Preventing Recurrence.},
  author = {Kasner SE and Bath PM and Hill MD and Volpi JJ and Giuffre M and Masuoka L and Wambeke D and Madeddu PR},
  year = {2025},
  journal = {Stroke},
  doi = {10.1161/strokeaha.124.048858},
  url = {https://doi.org/10.1161/strokeaha.124.048858}
}

RIS

TY  - JOUR
TI  - Recombinant Human Tissue Kallikrein-1 for Treating Acute Ischemic Stroke and Preventing Recurrence.
AU  - Kasner SE
AU  - Bath PM
AU  - Hill MD
AU  - Volpi JJ
AU  - Giuffre M
AU  - Masuoka L
AU  - Wambeke D
AU  - Madeddu PR
PY  - 2025
JO  - Stroke
DO  - 10.1161/strokeaha.124.048858
UR  - https://doi.org/10.1161/strokeaha.124.048858
ER  - 

APA

SE, K., PM, B., MD, H., JJ, V., M, G., L, M., D, W., & PR, M. (2025). Recombinant Human Tissue Kallikrein-1 for Treating Acute Ischemic Stroke and Preventing Recurrence.. Stroke. https://doi.org/10.1161/strokeaha.124.048858

Source records